Omeros - 48 Year Dividend Yield History | OMER

Historical dividend payout and yield for Omeros (OMER) since 1971. The current TTM dividend payout for Omeros (OMER) as of March 21, 2019 is $0.00. The current dividend yield for Omeros as of March 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.868B $0.030B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Smith & Nephew SNATS (SNN) United Kingdom $17.634B 0.00
ResMed (RMD) United States $14.469B 27.44
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Phibro Animal Health (PAHC) United States $1.308B 18.80
Meridian Bioscience (VIVO) United States $0.727B 21.67
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
United-Guardian (UG) United States $0.087B 20.01